Mikael Svensson

Professor of Applied Health Economics

I am a health economist and professor at the School of Public Health and Community Medicine at the University of Gothenburg in Sweden, and previously Professor in the Department of Pharmaceutical Outcomes & Policy at the University of Florida. My research focuses on economic evaluation in healthcare and public health, health technology assessment, and healthcare policy topics.

Latest from Substack

Loading latest posts...

Current Research Projects

Reproducible Cost-Effectiveness Models

Can we trust health economic evaluations of new pharmaceuticals? This Forte-funded project examines the reproducibility of pharmacoeconomic models and investigates the impact of researcher degrees of freedom in cost-effectiveness analyses of cancer drugs.

Learn more →

The Evidence-Base and Value of Cancer Drugs

Evaluating the clinical and cost-effectiveness evidence used in reimbursement decisions for new cancer drugs in Sweden. This project examines how surrogate endpoints and limited trial data impact drug pricing and healthcare costs.

Learn more →

MedPREP

The focus of MedPREP is on strengthening health system resilience through enhancing the robustness of medical preparedness - particularly the availability, production, and governance of critical pharmaceuticals.

Learn more →

Research Team

Ben Harvey

Post-Doc

Daniel Pouragheli

PhD Student

Thomas Lane

Research Assistant

Pedro Serra da Silva

Research Assistant

Phan Thuy Nhien Nguyen

Master's Student

Most Recent Publications

Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy

Sumaya Abuloha, Amie Goodin, Tianze Jiao, Manuela Corti and Mikael Svensson

Clinical Drug Investigation, 2026: in press.

Integrating smoking cessation into HIV care settings: a systematic review and meta-analysis of effectiveness and the evidence gap in cost-effectiveness

Van Minh Nguyen, Thanh Hoang, Yesim Tozan, Mikael Svensson, Hoang Van Minh and Nawi Ng

PLOS ONE, 2026: 21: e0350040.

Long-term study to assess quality of life and cost outcomes of different delayed breast reconstruction techniques: A randomized controlled trial (GoBreast)

Fredrik Brorson, Emma Hansson, Anna Paganini, Anna Elander and Mikael Svensson

Scandinavian Journal of Surgery, 2026: in press.

Peripheral Arterial Disease: Adverse Impacts, Disparities in Outcomes and the Path Ahead

Jonathan Golledge, Mette Sogaard, Mikael Svensson, Prem Chand Gupta, Sigrid Nikol, Paulo Eduardo Ocke Reis, Adrian Mahlmann and Gerry Fowkes

The Lancet, 2026: in press.

For a complete list of publications organized by topic, please visit my publications page or Google Scholar profile.

Policy & Advisory Roles

Beyond academia, I have extensive experience in the intersection of health economics research and decision-making. My experience includes:

The Dental and Pharmaceutical Benefits Agency (TLV)

Member of the Board for Pharmaceutical Benefits, deciding on pharmaceutical reimbursement in Sweden.

Region Västra Götaland

Committee member for the Structured Implementation of Healthcare Technologies (ordnat införande).

Advisory & Consulting

Advisor on health economics, economic evaluation, and HTA to international agencies and payers.

Teaching

Courses

In the academic year 26/27 I teach a course on advanced health economic evaluation methods and direct the master's thesis course, both in the Master's Programme in Public Health Science at the University of Gothenburg.

Teaching Material

My textbook on economic evaluation in healthcare (Studentlitteratur, in Swedish).